南模生物
(688265)
| 流通市值：12.29亿 | | | 总市值：19.40亿 |
| 流通股本：4938.85万 | | | 总股本：7796.35万 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 267,990,100.5 | 180,775,257.15 | 87,304,768.91 | 302,965,239.57 |
| 营业收入 | 267,990,100.5 | 180,775,257.15 | 87,304,768.91 | 302,965,239.57 |
| 二、营业总成本 | 295,805,196.53 | 192,754,449.08 | 101,776,392.04 | 336,226,283.66 |
| 营业成本 | 154,411,901.65 | 101,696,446.45 | 52,158,049.64 | 176,495,754.96 |
| 税金及附加 | 1,907,061.77 | 1,117,605.52 | 698,759.74 | 1,403,080.6 |
| 销售费用 | 39,427,556.29 | 24,837,511.82 | 11,165,270.92 | 37,105,500.7 |
| 管理费用 | 40,345,010.48 | 25,325,700.97 | 17,302,806.84 | 57,771,726.34 |
| 研发费用 | 58,347,615.01 | 39,267,376.81 | 19,799,024.04 | 65,756,129.94 |
| 财务费用 | 1,366,051.33 | 509,807.51 | 652,480.86 | -2,305,908.88 |
| 其中:利息费用 | 3,850,050.84 | - | - | 5,184,770.42 |
| 其中:利息收入 | 1,942,347.39 | - | - | 6,623,818.69 |
| 加:公允价值变动收益 | 2,085,618.72 | 1,889,742.56 | 483,827.91 | 1,821,274.41 |
| 加:投资收益 | 12,390,230.83 | 7,040,090.58 | 3,871,522.97 | 16,407,013.66 |
| 资产处置收益 | -10,923.26 | -10,923.26 | -36,908.32 | -57,085.17 |
| 资产减值损失(新) | -2,901,976.92 | -1,788,752.11 | -1,475,780.52 | -1,974,149.91 |
| 信用减值损失(新) | -5,081,490.95 | -3,213,094.13 | -4,744,432.18 | -6,709,047.73 |
| 其他收益 | 2,113,987.65 | 1,502,781.46 | 508,512.29 | 7,401,410.73 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -19,219,649.96 | -6,559,346.83 | -15,864,880.98 | -16,371,628.1 |
| 加:营业外收入 | 3.73 | 3.73 | - | 1,904,437.23 |
| 减:营业外支出 | 36,995.72 | 27,229.77 | 442.51 | 247,502.06 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -19,256,641.95 | -6,586,572.87 | -15,865,323.49 | -14,714,692.93 |
| 减:所得税费用 | -4,644,898.12 | -3,682,875.4 | -1,633,703.94 | -9,315,049.44 |
| 六、净利润 | -14,611,743.83 | -2,903,697.47 | -14,231,619.55 | -5,399,643.49 |
| 持续经营净利润 | -14,611,743.83 | -2,903,697.47 | -14,231,619.55 | -5,399,643.49 |
| 归属于母公司股东的净利润 | -14,611,743.83 | -2,903,697.47 | -14,231,619.55 | -5,399,643.49 |
| (一)基本每股收益 | -0.19 | -0.04 | -0.18 | -0.07 |
| (二)稀释每股收益 | -0.19 | -0.04 | -0.18 | -0.07 |
| 八、其他综合收益 | 810,853.08 | 747,854.93 | -206,358.94 | -125,528.65 |
| 归属于母公司股东的其他综合收益 | 810,853.08 | 747,854.93 | -206,358.94 | -125,528.65 |
| 九、综合收益总额 | -13,800,890.75 | -2,155,842.54 | -14,437,978.49 | -5,525,172.14 |
| 归属于母公司股东的综合收益总额 | -13,800,890.75 | -2,155,842.54 | -14,437,978.49 | -5,525,172.14 |
| 公告日期 | 2023-10-31 | 2023-08-31 | 2023-04-28 | 2023-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |